pepti

Search PeptiGuide

Popular searches

Oxytocin

Also known as: Pitocin, Syntocinon, The Love Hormone

At a glance

PeptiGuide dataset · reviewed Aug 2026

What it is

A 9-amino-acid hormone with approved obstetric use and still-uncertain intranasal behavioral research.

Status

FDA Approved

Typical dose

10–24iu

Researched for

Social bonding, anxiety, trust, emotional wellbeing

Trial progress

  1. PrePreclinical
  2. IPhase I
  3. IIPhase II
  4. IIIPhase III
  5. IVPhase IV
  6. FDAFDA approved

FDA approved - FDA-approved for specific uses with established human evidence

Stay current

Get updates on Oxytocin

New studies, regulatory decisions and data corrections - delivered when they land.

  • Oxytocin is identified as a 9-amino-acid hormone.
  • FDA-approved injectable use is tied to labor and postpartum bleeding contexts.
  • Intranasal research for trust, anxiety, autism, and social outcomes remains unsettled, with mixed human results.
  • Source-reported community intranasal use lists 10-24 IU as needed, while obstetric use is separately described under IV labeling or research contexts.

Oxytocin acts through the oxytocin receptor, a G-protein-coupled receptor described in the source as present in the uterus, breast tissue, and multiple brain areas including the amygdala. In peripheral tissues, signaling is linked to calcium-mediated uterine contraction and milk ejection. Central effects are described as modulation of fear, reward, and social-attention circuitry, but intranasal research is difficult to interpret because the amount reaching the brain is uncertain and may involve indirect pathways.

Where the research stands

The source treats injectable obstetric oxytocin as established, while describing intranasal behavioral research as contested. For social reward, a 2023 systematic review covering 19 randomized, double-blind, placebo-controlled studies and about 984 participants reported a clearer signal in brain-activity outcomes than in behavior or self-report. In autism research, the source cites a 2021 Scientific Reports randomized trial that did not find a substantial empathy-related neural activation change, and it notes that repeated-dose studies have ranged from modest social-behavior findings to no clear effect. Context and sex-specific differences are presented as important reasons the findings remain difficult to generalize. Short-term intranasal trial safety was described as reassuring, but the source does not establish a reliable clinical benefit for these investigational uses.

What it shows

Human clinical evidence

FDA-approved for specific uses with established human evidence

Limitations

Use only according to approved labeling and qualified medical guidance.

Bottom line: FDA approved for labor and postpartum use; other uses remain under research FDA approved for obstetric use

Typical dosing

Community

10–24 iu

intranasal as needed

10 iu40 iu

Community-reported intranasal use is described for social or bonding contexts; individual responses were reported as variable and this is not a dosing recommendation. · Intranasal

Research dosing

Indication-specific

Doses observed in studies

10-40 IU IV for labor

FDA Approved Labeling - Prescribed dose

Use only according to approved labeling and qualified medical guidance.

Duration
Single dose or short-term use
Administration
IV (obstetric); intranasal (research)

Best time to take

As needed in studied social or bonding contexts

As needed

Food recommendation

With or without food

Why this timing?

The source describes oxytocin effects as context-dependent and reports a 30-60 minute window before the intended effect in non-obstetric timing notes.

Not everyone experiences these. Individual responses vary with dose, duration, and personal factors.

  • Headache
  • Nausea and vomiting
  • Uterine hypertonicity
  • Blood pressure changes
  • Arrhythmias
  • Water intoxication
  • Maternal and fetal complications

Not everyone experiences side effects, and severity can vary by context, purity, route, and individual health factors.

H-Cys(1)-Tyr-Ile-Gln-Asn-Cys(1)-Pro-Leu-Gly-NH2; Cys1-Cys6 disulfide

One open dataset

Every fact on this page - doses, side effects, references - comes from the same PeptiGuide dataset that powers the Tracker, Compare, and the Lab.

Browse the dataset

Educational resource, not medical advice. Talk to your clinician before acting on anything here.

Community discussion

Comments are moderated before they appear. Keep it evidence-focused.